Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Abbvie Inc (ABBV)

92.25   -0.32 (-0.35%) 08-07 14:22
Open: 92.69 Pre. Close: 92.57
High: 92.99 Low: 92.21
Volume: 2,769,528 Market Cap: 162,806M
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 93.753 - 94.517 94.517 - 95.029
Low: 90.189 - 91.035 91.035 - 91.603
Close: 91.462 - 92.773 92.773 - 93.653

Technical analysis

as of: 2020-08-07 1:53:42 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 114.06     One year: 118.30
Support: Support1: 91.78    Support2: 76.36
Resistance: Resistance1: 97.65    Resistance2: 101.28
Pivot: 96.00
Moving Average: MA(5): 93.68     MA(20): 96.90
MA(100): 88.84     MA(250): 84.41
MACD: MACD(12,26): -0.94     Signal(9): -0.18
Stochastic oscillator: %K(14,3): 5.20     %D(3): 8.55
RSI: RSI(14): 34.06
52-week: High: 101.28  Low: 62.55  Change(%): 43.1
Average Vol(K): 3-Month: 812890  10-Days: 688949

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ABBV has closed above bottom band by 5.1%. Bollinger Bands are 24.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 07 Aug 2020
AbbVie a Top Ranked SAFE Dividend Stock With 5.1% Yield (ABBV) - Nasdaq

Fri, 07 Aug 2020
AbbVie settles California Humira lawsuit for $24M - Seeking Alpha

Wed, 05 Aug 2020
Chart Analysis: Get Key Insights on AbbVie Inc. (ABBV) - Invest Million

Tue, 04 Aug 2020
Time to Buy Beat-Down AbbVie Inc. (ABBV) Stock? Here is the INSIGHT - The InvestChronicle

Mon, 03 Aug 2020
AbbVie Inc.'s (NYSE:ABBV) P/E Is On The Mark - Yahoo Finance

Fri, 31 Jul 2020
AbbVie's (ABBV) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug ManufacturersGeneral
Shares Out. (M) 1,760
Shares Float (M) 1,470
% Held by Insiders 0.11
% Held by Institutions 76.76
Shares Short (K) 16,210
Shares Short P. Month (K) 19,200

Stock Financials

EPS 5.650
EPS Est This Year 5.530
EPS Est Next Year 6.560
Book Value (p.s.) -5.020
Profit Margin 24.77
Operating Margin 41.01
Return on Assets (ttm) 11.8
Return on Equity (ttm)
Qtrly Rev. Growth 10.1
Gross Profit (p.s.) 14.676
Sales Per Share 19.352
EBITDA (p.s.) 9.114
Qtrly Earnings Growth 22.60
Operating Cash Flow (M) 14,120
Levered Free Cash Flow (M) 9,260

Stock Valuations

PE Ratio 16.34
PEG Ratio
Price to Book value -18.39
Price to Sales 4.77
Price to Cash Flow 11.51

Stock Dividends

Dividend 4.500
Forward Dividend 4.720
Dividend Yield 0.05
Dividend Pay Date 2020-08-13
Ex-Dividend Date 2020-07-13
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.